In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma

Blood. 2007 Aug 15;110(4):1116-22. doi: 10.1182/blood-2007-01-067579. Epub 2007 May 4.

Abstract

Very low-dose irradiation (2 x 2 Gy) is a new, effective, and safe local treatment for follicular lymphoma. To understand the biologic mechanisms of this extremely effective response, we compared by microarray the gene-expression profile of patients' biopsies taken before and after radiation. In all patients, a major and consistent induction of p53 target genes was seen. p53 targets involved in cell-cycle arrest and apoptosis showed the same mode of regulation, indicating that, in vivo, both are activated simultaneously. p53 up-regulation and p53-mediated proliferation arrest and apoptosis were substantiated using immunohistochemistry, with activation of both the intrinsic and the extrinsic apoptotic pathways. The other induced genes revealed a whole set of biologically meaningful genes related to macrophage activation and TH1 immune response. Immunohistochemical analysis suggested a specific activation or differentiation of resident macrophages by apoptotic cells. These biologic insights are important arguments to advocate the use of low-dose radiotherapy as an effective palliative treatment for follicular lymphoma. Moreover, this study is the first in vivo report of the radiation-induced p53 apoptotic response in patients and suggests that this apoptotic response is not immunologically silent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Apoptosis / radiation effects
  • Female
  • Gamma Rays
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic / physiology*
  • Humans
  • Immunoenzyme Techniques
  • Lymphoma, B-Cell / genetics
  • Lymphoma, B-Cell / immunology
  • Lymphoma, B-Cell / radiotherapy
  • Lymphoma, Follicular / immunology*
  • Lymphoma, Follicular / radiotherapy*
  • Lymphoma, Large B-Cell, Diffuse / genetics
  • Lymphoma, Large B-Cell, Diffuse / immunology
  • Lymphoma, Large B-Cell, Diffuse / radiotherapy
  • Male
  • Middle Aged
  • Mutation
  • Oligonucleotide Array Sequence Analysis
  • RNA, Messenger / analysis
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • RNA, Messenger
  • Tumor Suppressor Protein p53